Antonio Perez-Martinez
Overview
Explore the profile of Antonio Perez-Martinez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
141
Citations
1201
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hernandez-Blanco C, Al-Akioui-Sanz K, Herrera L, Aguirre-Portoles C, Lozano-Ojalvo D, Perez-Rodriguez L, et al.
iScience
. 2025 Jan;
28(2):111698.
PMID: 39877904
The severity of COVID 19 symptoms has a direct correlation with lymphopenia, affecting natural killer (NK) cells. SARS-CoV-2 specific "memory" NK cells obtained from convalescent donors can be used as...
2.
Escamilla-Gomez V, Garcia Gutierrez V, Alcalde-Mellado P, Astibia-Mahillo B, Chinea-Rodriguez A, Lopez-Corral L, et al.
Bone Marrow Transplant
. 2024 Dec;
60(3):353-362.
PMID: 39663471
Ruxolitinib has been approved for the treatment of adults and pediatric patients ≥12 years with steroid refractory graft-versus-host disease (GvHD). However, real-life studies are needed to confirm the results of...
3.
Ruiz-Navarro J, Fernandez-Hermira S, Sanz-Fernandez I, Barbeito P, Navarro-Zapata A, Perez-Martinez A, et al.
Elife
. 2024 Oct;
13.
PMID: 39479958
We analyzed here how formin-like 1 β (FMNL1β), an actin cytoskeleton-regulatory protein, regulates microtubule-organizing center (MTOC) and multivesicular bodies (MVB) polarization and exosome secretion at an immune synapse (IS) model...
4.
Mingot-Castellano M, Reguera-Ortega J, Zafra Torres D, Hernani R, Lopez-Godino O, Guerreiro M, et al.
J Clin Med
. 2024 Sep;
13(17).
PMID: 39274330
Immune effector cell-associated hematotoxicity (ICAHT) is a frequent adverse event after chimeric antigen receptor (CAR)-T cell therapy. Grade ≥ 3 thrombocytopenia occurs in around one-third of patients, and many of...
5.
Badia X, Calleja M, Escudero-Vilaplana V, Perez-Martinez A, Pinana J, Poveda J, et al.
Orphanet J Rare Dis
. 2024 Aug;
19(1):308.
PMID: 39180132
Background: The aim of this study was to assess the contribution of the reflective multidisciplinary discussion in determining the value contribution of innovative drugs through the multi-criteria decision analysis (MCDA)....
6.
Bailen R, Iacoboni G, Delgado J, Lopez-Corral L, Hernani-Morales R, Ortiz-Maldonado V, et al.
Transplant Cell Ther
. 2024 Jul;
30(10):988.e1-988.e11.
PMID: 39069076
Chimeric antigen receptor (CAR)-T cell therapy is approved for the treatment of relapsed/refractory (R/R) large B cell lymphoma (LBCL). However, elderly patients might not be candidates for this therapy due...
7.
Sisinni L, Monserrate G, Hurtado J, Panesso M, Molina B, Fuentes C, et al.
Transplant Cell Ther
. 2024 Jul;
30(10):1015.e1-1015.e13.
PMID: 39067788
Haploidentical stem cell transplantation (Haplo-SCT) and cord blood transplantation (CBT) are both effective alternative treatments in patients suffering from acute myeloid leukemia (AML) and lacking a matched HLA donor. In...
8.
Gasior Kabat M, Li Y, Galan V, Mozo Y, Sisinni L, Bueno-Sanchez D, et al.
Cytotherapy
. 2024 Jul;
26(12):1458-1464.
PMID: 39046390
Memory T selected cells (CD45RA/RO) as donor lymphocyte infusion are less capable of producing alloreactivity and graft versus host disease (GvHD) compared with naïve T cells. The objective of this...
9.
Felgueres M, Esteso G, Garcia-Jimenez A, Dopazo A, Aguilo N, Mestre-Duran C, et al.
Sci Rep
. 2024 Jun;
14(1):13133.
PMID: 38849432
The short-lived nature and heterogeneity of Natural Killer (NK) cells limit the development of NK cell-based therapies, despite their proven safety and efficacy against cancer. Here, we describe the biological...
10.
Ascunce M, Coccolo A, Mozo Y, Baquero-Artigao F, Rodriguez-Molino P, Toro-Rueda C, et al.
Pediatr Infect Dis J
. 2024 May;
43(9):885-888.
PMID: 38713829
Hematopoietic stem cell transplant recipients are prone to infectious complications. Infections caused by nontuberculous mycobacteria have increased in adults but literature in children is scarce. We report 6 episodes of...